View Older Stories
-
Bernstein SocGen Group Reiterates Outperform Rating on Stryker (SYK), 'a buying opportunity here'
-
Stryker (SYK) PT Lowered to $383 at Raymond James
-
Stryker (SYK) PT Lowered to $355 at TD Cowen
-
Stryker (SYK) PT Lowered to $360 at Stifel
-
Stryker (SYK) PT Lowered to $350 at Wolfe Research
-
Bernstein SocGen Group Lowers Price Target on Stryker (SYK)
-
Stryker (SYK) PT Lowered to $379 at BTIG
-
Stryker (SYK) Misses Q1 EPS by 38c
-
Q1 MedTech quarterly preview: BTIG
-
Truist Securities on Stryker (SYK): guidance better than feared following cyberattack, could be 'clearing event'
-
Citi Adjusts Catalyst Watch List
-
Stryker Says Most Manufacturing Sites Restored After Hack - Bloomberg
-
Stryker reports network incident contained, manufacturing operations stabilizing
-
Stryker contains cyberattack, focuses on restoring customer systems
-
Stryker reports ongoing cyber incident disrupts operations
-
Stryker Hit With Suspected Cyberattack - WSJ
-
Citi Opens Catalyst Watch on Stryker (SYK)
-
Piper Sandler: 'When Will Things Turn in Med Tech and What Names to Own Now?'
-
William Blair Reiterates Outperform Rating on Stryker (SYK): "upside potential from international and M&A"
-
Jefferies Reiterates Buy Rating on Stryker (SYK): "view the setup favorably at the current valuation"
-
William Blair Starts Stryker (SYK) at Outperform
-
Stryker launches T2 Alpha Humerus Nailing System for complex fractures
-
Stryker launches limited release of Mako RPS handheld robotic system
-
Stryker (SYK) Declares $0.88 Quarterly Dividend; 1% Yield
-
Stryker (SYK) PT Raised to $454 at Needham
-
Canaccord Genuity Reiterates Buy Rating on Stryker (SYK)
-
Stryker (SYK) Reiterated at Market Outperform by Citizens: Milestones Notched in FY26
-
Stryker (SYK) PT Raised to $412 at BTIG
-
Stryker shares higher as fourth quarter results beat expectations
-
Stryker (SYK) Tops Q4 EPS by 8c, Beats on Revenue; Offers FY26 EPS Guidance
-
Piper Sandler on Stryker (SYK): 'We Encourage Investors to Build Positions in the Name'
-
TD Cowen Assumes Stryker (SYK) at Hold, 'Positive Story Well Understood'
-
Bernstein Highlights Top U.S. Medtech 2026 Picks: 'Sector Poised For a Rebound'
-
Who in MedTech could get acquired at this year's healthcare investor conference in SF? Piper answers
-
Raymond James Upgrades Stryker (SYK) to Outperform
-
Increasing unusual put option volume: INVZ BAX FITB EWJ SYK LW BMRN PPLT EQNR HYMC
-
Citizens Upgrades Stryker (SYK) to Market Outperform
-
Stryker (SYK) Raises Quarterly Dividend 4.8% to $0.88; 1% Yield
-
This is the best orthopedics stock to own in 2026, Wolfe says
-
Piper Sandler Shares Medical Technology and Devices Stock Thoughts Post Ortho KOL Call
-
Bernstein Reiterates Outperform Rating on Stryker (SYK) on Bullish Outlook
-
Stryker (SYK) PT Raised to $400 at Truist Securities
-
RBC Capital Sees 'Durable Growth Ahead' for Stryker (SYK)
-
Bernstein on Stryker (SYK): 'Bullish Outlook Focused on Growth and Continued Margin Expansion'
-
Needham Reiterates Buy Rating on Stryker (SYK)
-
Canaccord Genuity Reiterates Buy Rating on Stryker (SYK)
-
Stryker (SYK) PT Lowered to $450 at Bernstein SocGen Group
-
Stryker (SYK) PT Raised to $410 at BTIG
-
Stryker (SYK) Tops Q3 EPS by 6c; raises guidance
-
Evercore Adds Names to TAP Lists

